Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophen...
Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil
About this item
Full title
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
This prospective study investigated the efficiency of the tacrolimus (Tac) combined with mycophenolate mofetil (MMF) alone without immunoadsorption (IA) or plasmapheresis (PPH) as treatment for early (within 2 weeks) acute humoral rejection (AHR) in non-sensitized renal allograft recipients. Of 160 patients enrolled in this prospective study, 11 pa...
Alternative Titles
Full title
Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_68378454
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68378454
Other Identifiers
ISSN
0085-2538
E-ISSN
1523-1755
DOI
10.1038/sj.ki.5001870
